Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer. - Chen DD; Zimmer A; Yang DD; Francini E; Patton R; Crowdis J; Chandra P; Bin Riaz I; Hanratty B; Rickles-Young M; Tsuji J; Cibulskis C; et al. (NPJ precision oncology, 2026)